- Condition: The Primary Outcome of This Study Will be the Rate of Endometritis in the Study Population.
Interventions: Drug: Postpartum Antibiotics; Drug: No postpartum antibiotics
Sponsors: Washington University School of Medicine; Washington University School of Medicine; St. Louis University
Recruiting - verified April 2012 - Conditions: Snoring; Strep Throat
Interventions: Other: No postoperative antibiotic; Drug: Amoxicillin; Drug: Amoxicillin/clavulanate potassium; Drug: Azithromycin; Drug: Cefaclor; Drug: Cephalexin; Drug: Cefdinir; Drug: Clindamycin
Sponsors: University of Missouri-Columbia; University of Missouri-Columbia
Recruiting - verified March 2012 - Conditions: Skin and Soft Tissue Abscess; Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
Intervention: Drug: Oral Clindamycin
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital
Recruiting - verified December 2011 - Condition: Acne Vulgaris
Interventions: Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel alone; Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
Sponsors: Zeichner, Joshua, M.D.; Zeichner, Joshua, M.D.
Recruiting - verified August 2011 - Condition: Infections, Pediatrics
Interventions: Drug: Ceftaroline fosamil; Drug: Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam; Drug: Cephalexin or Clindamycin
Sponsors: Cerexa, Inc.; Cerexa, Inc.; AstraZeneca
Recruiting - verified May 2012 - Conditions: Bacterial Infection; Anti-infective Agents; Breast Implantation
Interventions: Drug: Cefadroxil discontinued early; Drug: Cefadroxil until drain removal
Sponsors: Stony Brook University; Stony Brook University; Plastic Surgery Educational Foundation
Recruiting - verified March 2012 - Condition: Methicillin-Resistant S.Aureus
Interventions: Drug: Cephalexin; Drug: Placebo; Drug: Trimethoprim-sulfamethoxazole (TS); Drug: Clindamycin
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Condition: Methicillin-Resistant S.Aureus
Interventions: Drug: Clindamycin; Drug: Placebo; Drug: Trimethoprim-sulfamethoxazole (TS)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Condition: Skin Diseases, Infectious
Interventions: Drug: Daptomycin; Drug: Vancomycin, Clindamycin or semi-synthetic Penicillins
Sponsors: Cubist Pharmaceuticals; Cubist Pharmaceuticals
Recruiting - verified February 2012
 |
Clindamycin Clinical Trials |
